GATA3 expression was shown to be required for the high mobility group box-containing factor TCF7L2 to bind to about 50% of TCF7L2 sites in the ER-positive breast cancer cell line MCF-7, and these sites were enriched in GATA3 but not TCF7L2 motifs [148]. This evidence concerns the gene GATA3 and breast carcinoma.